Assessing the relationship of paraoxonase-1 Q192R polymorphisms and the severity of lung disease in SM-exposed patients.

MLA

Golmanesh, Leila, et al. “Assessing the Relationship of Paraoxonase-1 Q192R Polymorphisms and the Severity of Lung Disease in SM-Exposed Patients.” Immunopharmacology and Immunotoxicology, vol. 35, no. 3, June 2013, pp. 419–25. EBSCOhost, https://doi.org/10.3109/08923973.2013.797993.

APA

Golmanesh, L., Bahrami, F., Pourali, F., Vahedi, E., Wahhabaghai, H., Mehrani, H., & Ghanei, M. (2013). Assessing the relationship of paraoxonase-1 Q192R polymorphisms and the severity of lung disease in SM-exposed patients. Immunopharmacology and Immunotoxicology, 35(3), 419–425. https://doi.org/10.3109/08923973.2013.797993

Chicago

Golmanesh, Leila, Farideh Bahrami, Fatemeh Pourali, Ensieh Vahedi, Hannaneh Wahhabaghai, Hossein Mehrani, and Mostafa Ghanei. 2013. “Assessing the Relationship of Paraoxonase-1 Q192R Polymorphisms and the Severity of Lung Disease in SM-Exposed Patients.” Immunopharmacology and Immunotoxicology 35 (3): 419–25. doi:10.3109/08923973.2013.797993.